RNF122 and central nervous system cancer: Based on univariate and multivariate Cox regression analyses, RNF122 mRNA expression level was correlated to WHO stage; hence, it was found to be an independent predictor of unfavorable survival outcomes in glioma patients (Table S2), indicating that RNF122 might be a potential glioma biomarker.